Skip to content
10-K

Annual Report

XENETIC BIOSCIENCES, INC. XBIO

0001683168-26-001737

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 6, 2026 2.29M sh
Shares Diluted FY 2025 · Dec 31, 2025 1.7M sh
Shares Diluted FY 2025 · Dec 31, 2024 1.54M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$2.29M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$2.82M
Cash And Equivalents FY 2025 · Dec 31, 2025 $7.88M
Cash And Equivalents FY 2025 · Dec 31, 2024 $6.17M
Cash And Equivalents FY 2025 · Dec 31, 2023 $8.98M
Stockholders Equity FY 2025 · Dec 31, 2025 $7.4M
Stockholders Equity FY 2025 · Dec 31, 2024 $6.01M
Stockholders Equity FY 2025 · Dec 31, 2023 $9.8M
Current Liabilities FY 2025 · Dec 31, 2025 $968.03K
Current Liabilities FY 2025 · Dec 31, 2024 $894.26K
Total Liabilities FY 2025 · Dec 31, 2025 $968.03K
Total Liabilities FY 2025 · Dec 31, 2024 $894.26K
Current Assets FY 2025 · Dec 31, 2025 $8.05M
Current Assets FY 2025 · Dec 31, 2024 $6.59M
Total Assets FY 2025 · Dec 31, 2025 $8.36M
Total Assets FY 2025 · Dec 31, 2024 $6.9M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.58
Eps Diluted FY 2025 · Dec 31, 2024 −$2.57
Eps Basic FY 2025 · Dec 31, 2025 −$1.58
Eps Basic FY 2025 · Dec 31, 2024 −$2.57
Sga Expense FY 2025 · Dec 31, 2025 $2.75M
Sga Expense FY 2025 · Dec 31, 2024 $3.42M
Rd Expense FY 2025 · Dec 31, 2025 $3.07M
Rd Expense FY 2025 · Dec 31, 2024 $3.29M
Net Income FY 2025 · Dec 31, 2025 −$2.68M
Net Income FY 2025 · Dec 31, 2024 −$3.96M
Operating Income FY 2025 · Dec 31, 2025 −$2.83M
Operating Income FY 2025 · Dec 31, 2024 −$4.2M
Revenue FY 2025 · Dec 31, 2025 $2.98M
Revenue FY 2025 · Dec 31, 2024 $2.5M